SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-09-072181
Filing Date
2009-12-31
Accepted
2009-12-31 16:44:40
Documents
2
Period of Report
2009-12-31
Items
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a09-36951_18k.htm 8-K 30172
2 EX-4.1 a09-36951_1ex4d1.htm EX-4.1 44379
  Complete submission text file 0001104659-09-072181.txt   76360
Mailing Address 119 FOURTH AVE NEEDHAM MA 02494-2725
Business Address 119 FOURTH AVE NEEDHAM MA 02494 7814330771
Celldex Therapeutics, Inc. (Filer) CIK: 0000744218 (see all company filings)

IRS No.: 133191702 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-15006 | Film No.: 091268837
SIC: 2835 In Vitro & In Vivo Diagnostic Substances